Blog

Company News

Industry Trends

Laws Regulations

All Categories >

01

2024-11

CDE Releases “Common Issues and Technical Requirements for Replicable Lentiviral Vector Testing”

On October 29, the Center for Drug Evaluation of the National Medical Products Administration released the “Common Issues and Technical Requirements for Replicable Lentiviral Vector Testing.” The issuance of these technical requirements aims to enhance the standardization of pharmaceutical R&D and regulatory submissions by biopharmaceutical companies, establish a scientifically sound and standardized review and approval system, and accelerate the high-quality development of cell and gene therapy products in China.

2024-11-01

He Yousheng

09

2024-10

Good News | Hycells Awarded the Filing Certificate for Class I Medical Device Production

Recently, Heyou Bio successfully obtained the “Registration Certificate for Class I Medical Device Manufacturing” issued by the Minhang District Administration for Market Regulation of Shanghai (Registration No.: Hu Min Yao Jian Xie Sheng Chan Bei 20243438), marking official recognition of Heyou Bio’s innovative achievements in the field of CAR positivity rate testing.

2024-10-09

He Yousheng

22

2024-09

Statement on the Label Change for Hycells’s New Product

Dear Sir/Madam, We would like to express our heartfelt gratitude for your organization’s unwavering support and trust in Hycells over the years.

2024-09-22

He Yousheng

18

2024-09

Good News | Hycells Awarded the Title of “Shanghai Specialized, Refined, Distinctive, and Innovative SME” for 2024

2024年9月6日， 上海市经济和信息化委员会发布了《2024年上海市专精特新中小企业名单(第二批)》公示名单，上海合佑生生物科技有限公司也非常荣幸位列其中。

2024-09-18

He Yousheng

10

2024-09

Minhang District Talent Bureau and Hycells Build a “Concentric Circle” of Industry-Talent Services

Talent is the “primary resource” for enterprises. To attract and retain top talent, Shanghai has introduced a series of policies on household registration for high-caliber professionals, thereby empowering corporate development. This year, with the establishment of talent service bureaus in each district of Shanghai, the “green channel” between talent service agencies and businesses has been further streamlined. Through mechanisms such as policy-driven entry into industrial parks, tailored guidance for scaling up operations, and direct on-site services for enterprises, the city has continuously refined its proactive service delivery model, deploying a coordinated package of door-to-door support initiatives to build a concentric “circle” of industry–talent services.

2024-09-10

He Yousheng

26

2024-08

Disease Sample Services | Compliance-Focused Collection Services for Autoimmune Disease Samples Empower the Hundreds-of-Billion-Dollar Autoimmune Market

Autoimmune diseases (AIDs) are immune dysregulatory disorders in which the body’s normal autoimmune homeostasis is disrupted, leading to aberrant immune responses against self-cell or tissue antigens and, consequently, damage to or dysfunction of autologous tissues. AIDs affect 5% to 8% of the global population, imposing substantial suffering on patients; their incidence may even surpass that of cardiovascular disease and cancer, making them a leading cause of mortality worldwide.

2024-08-26

He Yousheng
< 1...101112...18 >